Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 34 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DOCTEUR MATUS ONCOLOGY from Trooz, company number BE0886451623, closed financial year 2025 with a result of € 101,630 after tax. For that financial year DOCTEUR MATUS ONCOLOGY recorded a gross margin of € 218,040 and equity of € 298,315. Compared with financial year 2024, the result moved from € 129,900 to € 101,630. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 298,315
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 101,630
▼ 22% vs 2024
Profit after tax over the fiscal year.
€ 28,369
▼ 57% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 78,000 paid out
77 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 20,617
▲ 178% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 355,719
▼ 6% vs 2024
€ 25,152 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 135,030 | € 371,678 | € 262,708 | € 218,040 | ▼ 17% |
| Profit after taxes | € 40,878 | € 215,785 | € 129,900 | € 101,630 | ▼ 22% |
| Equity | € 79,000 | € 144,785 | € 274,685 | € 298,315 | ▲ 9% |
| Total debts | € 465,085 | € 634,213 | € 405,480 | € 434,861 | ▲ 7% |
| Cash | € 11,527 | € 80,148 | € 66,338 | € 28,369 | ▼ 57% |
| Land & buildings | € 309,167 | € 285,833 | € 262,500 | € 239,167 | ▼ 9% |
| Retained profit | € 78,000 | € 143,785 | € 273,685 | € 297,315 | ▲ 9% |
| Dividend | € 4,160 | € 150,000 | € 0 | € 78,000 | |
| Bank debt | € 429,157 | € 404,635 | € 379,693 | € 355,719 | ▼ 6% |
| Balance sheet total | € 544,085 | € 778,998 | € 680,165 | € 733,176 | ▲ 8% |
Key figures of DOCTEUR MATUS ONCOLOGY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DOCTEUR MATUS ONCOLOGY?
What happened at DOCTEUR MATUS ONCOLOGY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 101,630 (▼ 22% vs 2024). filed late Source: NBB ↗
- Geoffrey MATUS stepped down as director. NBB
- New establishment in Trooz. KBO
- Start of the company according to the CBE. KBO
- Geoffrey MATUS became a director. NBB
In short
From € 40,878 profit in 2022 to € 101,630 profit in 2025.
Paid € 197,914 in corporate taxes since 2022.
Best year ever: 2023, with € 215,785 profit.
Paid out € 232,160 in dividends to the owners in total.
A new publication or filing at DOCTEUR MATUS ONCOLOGY? We notify you, reason included.
Follow DOCTEUR MATUS ONCOLOGYDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Geoffrey MATUS
Director
since 2006 · until 2024
Establishments
Establishment units
Physical locations of this company
Rue du Boultay 11
4870 Trooz
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0886.451.623
- VAT number
- BE 0886.451.623
- Registered office
- Rue du Boultay 11, 4870 Trooz
- Names & denominations
- DOCTEUR MATUS ONCOLOGY
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 January 2007
- Peppol
- Active · Active since 7 Jan 2026
- Activities · NACE
Activiteiten van medisch specialisten